Skip to content
OpenCapital
Get started

Esperion Therapeutics ESPR Enterprise value

Enterprise value at other companies

Amgen logo
AmgenAMGN
$246.43B+9.9%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$81.42B+18.1%
NewAmsterdam Pharma Company logo
NewAmsterdam Pharma CompanyNAMS
$3.22B+115%
Lexicon Pharmaceuticals logo
Lexicon PharmaceuticalsLXRX
$651.56M+210%
Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
$684.98M+89.8%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$452.74M+5.3%

Other financials

Income statement

See full
Revenue$80.1M+23.2%
Operating income-$6.6M+70.2%
Net income-$25.2M+37.7%
EPS (diluted)-$0.10+52.4%

Balance sheet

See full
Cash & equivalents$156.2M+36.2%
Total debt$155.2M+6.1%
Total equity-$307.9M+27.8%
Total assets$462.5M+42.7%

Cash flow

See full
Operating cash flow-$27.7M-22.5%
CapEx$189.0K—
Free cash flow-$27.9M-23.3%

Valuation

See full
Market cap$811.73M+283%
P/S1.9×+1.1×

Profitability

See full
Operating margin18.1%+12.7pp
Net margin-34.8%+8.0pp
FCF margin-30.7%—

Returns & leverage

See full
Return on equity-260.8%—
Debt / equity0.8×—
Current ratio1.5×+0.4×

Where this comes from

Calculated from Esperion Therapeutics’s reported figures.

$703.7Mmarket cap+$155.2Mtotal debt−$156.2Mcash and equivalents=$702.74M

The official record: Esperion Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Esperion Therapeutics's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Esperion Therapeutics's enterprise value?
Esperion Therapeutics (ESPR) reported enterprise value of $702.74M in Q1 2026.
How has Esperion Therapeutics's enterprise value changed year-over-year?
Esperion Therapeutics's enterprise value increased by 122.0% year-over-year, from $316.51M to $702.74M.
What is the long-term trend for Esperion Therapeutics's enterprise value?
Over 5 years (2020 to 2025), Esperion Therapeutics's enterprise value has grown at a -8.1% compound annual growth rate (CAGR), from $1.32B to $864.28M.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.